Le Lézard6m
Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression
Compass Pathways plc , a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced the publication of results from the COMP004 study, an ...
PharmiWeb1h
Global Urea Cycle Disorder Treatment Market to Reach USD 771.0 Million by 2035, Expanding at a CAGR of 3.5% - Transparency Market Research, Inc.
The global industry was valued at US$ 527.5 Mn in 2024 and is projected to exceed US$ 771.0 Mn by 2035, growing at a CAGR of ...
Altimmune: Pemvidutide Differentiation Advancement In MASH Space Continues To Shine
Explore the promising potential of Altimmune, Inc.'s Pemvidutide in NASH, AUD, & obesity treatment, with key trials underway.
The Manila Times22h
Progress Update on Halberd, Athena GTX and Athena Telemedicine Partnership, LLC Joint Projects
The US Government Granted Athena GTX a $2,866,000 Final Development Contract Award!
Medindia22h
HepQuant to Present at Key Liver Conferences to Highlight Applications of HepQuant DuO - a Quantitative Liver Health Test
PR Newswire DENVER Recent clinical data demonstrate how HepQuant DuO test results may be used to inform endoscopy screening decisions, monitor disease progression ...
BYU defies low expectations and overcomes slow start to become a team to watch in March Madness
A lot of hopes rest on Saunders, who has gone from more of a role player to BYU's primary scorer. He was named the Big 12's ...
FAU's Final Four team reunites in the NCAA Tournament after players, coach scattered
The former Florida Atlantic starters — now scattered across the country and playing for other teams — landed on the same side ...